In vitro treatment of congenital disorder of glycosylation type Ia using PLGA nanoparticles loaded with GDP‑Man-Reference-Cited by-同舟云学术

In vitro treatment of congenital disorder of glycosylation type Ia using PLGA nanoparticles loaded with GDP‑Man

Published:2019-05-16 Issue: Volume: Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Bortot Barbara¹,De Martino Eleonora²,Tesser Alessandra¹,Ura Blendi¹,Ruozi Barbara³,Aloisio Michelangelo¹,Biffi Stefania¹,Addobbati Riccardo¹,Tosi Giovanni³,Dolcetta Diego⁴,Severini Giovanni¹

Affiliation:

1. Institute for Maternal and Child Health‑IRCCS ‘Burlo Garofolo’, I‑34137 Trieste, Italy

2. DSM, Department of Medical Sciences, University of Trieste, I‑34149 Trieste, Italy

3. Department of Life Sciences, University of Modena and Reggio Emilia, I‑41121 Modena, Italy

4. UOSD SAFU, RiDAIT Department, The Regina Elena National Cancer Institute, I‑00144 Rome, Italy

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune cell receptor-specific nanoparticles as a potent adjuvant for nasal split influenza vaccine delivery;Nanotechnology;2024-01-04

2. Macrophage-targeted mannose-decorated PLGA-vegetable oil hybrid nanoparticles loaded with anti-inflammatory agents;Colloids and Surfaces B: Biointerfaces;2022-05

3. Chemical Therapies for Congenital Disorders of Glycosylation;ACS Chemical Biology;2021-11-17

4. New and potential strategies for the treatment of PMM2-CDG;Biochimica et Biophysica Acta (BBA) - General Subjects;2020-11

5. Proteostasis regulators as potential rescuers of PMM2 activity;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2020-07